Azenta officer reports 13,042 RSU grant and 38,755 shares owned

Rhea-AI Filing Summary

Azenta, Inc. (AZTA) reported an equity award to one of its senior executives. On 11/24/2025, the company’s SVP and GM, Multiomics received 13,042 restricted stock units (RSUs) of Azenta common stock at a grant price of $0.00 per unit. After this grant, the executive beneficially owns 38,755 shares of Azenta common stock in total, held directly.

The filing explains that the RSU amount was calculated by dividing the target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting and will vest in three equal installments of 33 1/3% per year, starting on November 24, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Zhou Ginger

Role SVP and GM, Multiomics

Type	Security	Shares	Price	Value
Grant/Award	Common	13,042	$0.00	--

Holdings After Transaction: Common — 38,755 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zhou Ginger

(Last) (First) (Middle)

C/O AZENTA, INC.

200 SUMMIT DRIVE, 6TH FLOOR

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Azenta, Inc. [ AZTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and GM, Multiomics

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	11/24/2025		A		13,042(1)	A	$0.00	38,755	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.

	/s/Ephraim Starr, Attorney-in-fact for Ginger Zhou	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity award was reported for Azenta (AZTA) in this Form 4?

The Form 4 reports a grant of 13,042 restricted stock units (RSUs) of Azenta, Inc. common stock to the company’s SVP and GM, Multiomics.

When were the Azenta (AZTA) RSUs granted and to whom?

The RSUs were granted on 11/24/2025 to an officer of Azenta who serves as SVP and GM, Multiomics.

How do the Azenta (AZTA) RSUs vest for the executive?

The RSUs are subject to time-based vesting and will vest 33 1/3% per year, beginning on November 24, 2026.

How was the number of Azenta (AZTA) RSUs in this grant determined?

The filing states the number of RSUs was determined by dividing the target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date.

What is the total Azenta (AZTA) share ownership reported after this transaction?

Following the RSU grant, the executive is reported to beneficially own 38,755 shares of Azenta, Inc. common stock, held directly.

Did the executive pay anything for the Azenta (AZTA) RSU grant?

No. The explanation notes that no amount was paid upon grant of the restricted stock units.